MXPA05003283A - Composicion de polimero y formas de dosis que comprenden la misma. - Google Patents
Composicion de polimero y formas de dosis que comprenden la misma.Info
- Publication number
- MXPA05003283A MXPA05003283A MXPA05003283A MXPA05003283A MXPA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A MX PA05003283 A MXPA05003283 A MX PA05003283A
- Authority
- MX
- Mexico
- Prior art keywords
- same
- dosage forms
- polymer composition
- dosage form
- composition
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se proporciona una composicion que comprende un alto peso molecular, un polimero soluble en agua que tiene un punto de turbidez de aproximadamente 20° a aproximadamente 90°C y un polimero gelificante; la composicion se puede utilizar como un componente de una formula de dosis farmaceutica, como la cubierta de una forma de dosis, como una matriz comestible, es decir, una forma de dosis farmaceutica per se.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
| PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
| PCT/US2003/008960 WO2004028514A1 (en) | 2002-09-28 | 2003-03-21 | Polymer composition and dosage forms comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05003283A true MXPA05003283A (es) | 2005-11-23 |
Family
ID=34271652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05003283A MXPA05003283A (es) | 2002-09-28 | 2003-03-21 | Composicion de polimero y formas de dosis que comprenden la misma. |
Country Status (8)
| Country | Link |
|---|---|
| JP (3) | JP2006517183A (es) |
| CN (3) | CN1700907A (es) |
| AT (1) | ATE444739T1 (es) |
| AU (4) | AU2003218359A1 (es) |
| BR (5) | BR0314787A (es) |
| CA (3) | CA2500312A1 (es) |
| DE (2) | DE60335270D1 (es) |
| MX (1) | MXPA05003283A (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2470463C (en) | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
| SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| EP2299986A1 (en) * | 2008-06-19 | 2011-03-30 | University Of The Witwatersrand, Johannesburg | A chronotherapeutic pharmaceutical dosage form |
| JPWO2011118454A1 (ja) * | 2010-03-23 | 2013-07-04 | リンテック株式会社 | 固形製剤 |
| EP2729180B1 (en) * | 2011-07-08 | 2019-01-23 | The University of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| WO2013119466A1 (en) * | 2012-02-07 | 2013-08-15 | Mcneil-Ppc, Inc. | Rapidly disintegrating coated tablets |
| US9693962B2 (en) * | 2012-06-05 | 2017-07-04 | Takeda Pharmaceutical Limited | Dry-coated tablet |
| BR112017005574A2 (pt) * | 2014-09-19 | 2017-12-12 | Procter & Gamble | formas de dosagem de liberação pulsada de fenilefrina |
| US11419824B2 (en) | 2017-12-29 | 2022-08-23 | Laxxon Medical Ag | Drug delivery system |
| US11752107B2 (en) * | 2021-07-30 | 2023-09-12 | Evecxia Therapeutics, Inc. | 5-hydroxytryptophan gastroretentive dosage forms |
| CN115295864B (zh) * | 2021-11-09 | 2023-08-11 | 深圳市德方创域新能源科技有限公司 | 正极补锂添加剂及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07507564A (ja) * | 1992-09-30 | 1995-08-24 | ファイザー・インク． | コア及び厚さが一定でないコーティングを含有する物品 |
| GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| IT1282576B1 (it) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
| US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
| AU2001250646A1 (en) * | 2000-04-17 | 2001-10-30 | Yamanouchi Pharmaceutical Co..Ltd. | Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof |
| BR0206825A (pt) * | 2001-02-13 | 2004-02-25 | Astrazeneca Ab | Formulação de dispersão sólida de liberação modificada, multiparticulada, processo para a preparação da formulação, uso da mesma, tablete, e, métodos para o tratamento de uma doença cardiovascular, e, para o tratamento de câncer |
-
2003
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 AT AT03714356T patent/ATE444739T1/de not_active IP Right Cessation
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/zh active Pending
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/pt not_active IP Right Cessation
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/ja active Pending
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/pt not_active Application Discontinuation
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/zh active Pending
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/ja active Pending
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/pt not_active Application Discontinuation
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/pt not_active Application Discontinuation
- 2003-03-21 DE DE60335270T patent/DE60335270D1/de not_active Expired - Lifetime
- 2003-03-21 DE DE60329614T patent/DE60329614D1/de not_active Expired - Lifetime
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/zh active Pending
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/es unknown
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/pt not_active Application Discontinuation
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2500311A1 (en) | 2004-04-08 |
| CA2500312A1 (en) | 2004-04-08 |
| DE60329614D1 (de) | 2009-11-19 |
| JP2006517514A (ja) | 2006-07-27 |
| BR0314787A (pt) | 2005-07-26 |
| JP2006517182A (ja) | 2006-07-20 |
| AU2003220466A1 (en) | 2004-04-19 |
| CA2500313C (en) | 2011-06-07 |
| AU2003218359A1 (en) | 2004-04-19 |
| ATE444739T1 (de) | 2009-10-15 |
| BR0314777A (pt) | 2005-07-26 |
| CA2500313A1 (en) | 2004-04-08 |
| BR0314781A (pt) | 2005-07-26 |
| AU2003220472A1 (en) | 2004-04-19 |
| BR0314547A (pt) | 2005-08-09 |
| BR0314804A (pt) | 2005-08-02 |
| AU2003225944A1 (en) | 2004-04-19 |
| CN1700908A (zh) | 2005-11-23 |
| CN1684671A (zh) | 2005-10-19 |
| CN1700907A (zh) | 2005-11-23 |
| JP2006517183A (ja) | 2006-07-20 |
| DE60335270D1 (de) | 2011-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0103033A (pt) | Partìculas farmacêuticas de sabor mascarado | |
| AU2003231126A1 (en) | Chewable soft capsule | |
| GB0614353D0 (en) | Oral compositions, their preparation and use | |
| ATE355829T1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
| TWI255722B (en) | Non-gelatin type encapsulating composition and capsule obtained therefrom | |
| CA2331264A1 (en) | Compositions and methods for drug delivery | |
| DE60305724D1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
| WO2002101412A3 (en) | Spray freeze-dried compositions | |
| DE69803940D1 (de) | Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe | |
| CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
| MXPA05001061A (es) | Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol. | |
| MXPA05003283A (es) | Composicion de polimero y formas de dosis que comprenden la misma. | |
| DE69906269T2 (de) | Wässriges verfahren zur herstellung fester paroxetin-dispersionen | |
| CA2444203A1 (en) | Pet food composition containing semi-refined gelling agent | |
| BR0015197A (pt) | Copolìmero vinìlico, e, composição | |
| MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| NO20050247L (no) | Lavmolekylaert oversulfatert polysakkarid | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| DE60103619D1 (de) | Pharmazeutische zubereitungen enthaltend alginate | |
| BRPI0212195B8 (pt) | composições contendo pectina e ácido ascórbico | |
| ATE291058T1 (de) | Vernetzerfreie zubereitungen | |
| EP1571175A4 (en) | PROCESS FOR PRODUCING POLYETHER POLYMER COMPOSITION, POLYETHER POLYMER COMPOSITION, AND SOLID ELECTROLYTE FILM | |
| WO2004030469A3 (en) | Gelling composition | |
| MY141808A (en) | Indomethacin external preparation |